ProfileGDS5822 / ILMN_1236864
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 48% 30% 43% 21% 5% 39% 46% 32% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 121.148
GSM1276600PDAC Late Ablation Control 217.230
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 116.843
GSM1276603PDAC Late Ablation 212.321
GSM1276604PDAC Late Ablation 35.85
GSM1303940PDAC Late Ablation_anti-CTLA4 118.139
GSM1303941PDAC Late Ablation_anti-CTLA4 222.746
GSM1303942PDAC Late Ablation_anti-CTLA4 315.732